Overview

Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

Status:
Completed
Trial end date:
2020-11-23
Target enrollment:
Participant gender:
Summary
In this research, the study team will use brain imaging to evaluate the presence of neuroinflammation in the brains and spinal cords of patients with low back pain, and whether CBD effects levels of neuroinflammation. The efficacy of CBD use for low back pain treatment will also be evaluated by observing whether CBD administration will reduce neuroinflammation and low back pain symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Cannabidiol
Epidiolex